Jessica Goldenberg
About Jessica Goldenberg
Jessica Goldenberg is an Associate Director and Clinical Scientist at Adaptimmune, where she has worked since 2020 in Philadelphia, Pennsylvania. She has extensive experience in clinical research, having held various roles in project management and clinical operations across multiple organizations.
Work at Adaptimmune
Jessica Goldenberg has served as Associate Director, Clinical Scientist at Adaptimmune since 2020. In this role, she is based in Philadelphia, Pennsylvania, and has been integral to the company's clinical research initiatives. Her responsibilities include managing complex clinical research projects and overseeing global feasibility studies, which are essential for the development of innovative therapies.
Education and Expertise
Jessica Goldenberg holds a Bachelor of Arts degree in Psychology, Neural and Behavioral Sciences from Bryn Mawr College, which she completed in 2003. She furthered her education at Temple University School of Pharmacy, earning a Master of Science in Regulatory Affairs and Quality Assurance from 2010 to 2014. Her educational background supports her extensive expertise in clinical research and regulatory compliance.
Background
Jessica Goldenberg has a diverse professional background in clinical research. Prior to her current position at Adaptimmune, she worked in various roles including Project Manager at ACI Clinical and Clinical Scientist at Inovio Pharmaceuticals Inc. Her career spans over a decade, with experience in managing protocols, investigator sites, and vendor management in clinical trials.
Achievements
Throughout her career, Jessica Goldenberg has demonstrated her capability in managing multiple protocols and conducting site selection, initiation, interim, and close-out visits for clinical trials. She possesses a strong working knowledge of ICH/GCP guidelines, which are critical for ensuring compliance and quality in clinical trial management. Her experience includes roles at notable organizations such as Quintiles, IQVIA, and Yale University School of Medicine.